CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and ...
Ophthalmologist J. William Harbour, MD, has received a research grant from the Melanoma Research Foundation, according to a Missourian report. Dr. Harbour works at Washington University's School of ...
Ophthalmologist J. William Harbour, MD, has identified a new genetic marker for determining the virulence of ocular melanomas, according to a news release. The study, “Recurrent mutations at codon 625 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback